College of Nursing & Professional Disciplines

Updates for students, alumni, and supporters

CNPD Research News: April 2023

CNPD Accomplishments

Congratulations to Frank Johnson on his recent publication! Johnson, F., Jr, RedCloud, A., Mootz, J., Hallgren, K.A., Elliot, K., Alexander, C., Aanji’bide Community Action Board, & Greenfield, B. L. (2023). Community member perspectives on adapting the cascade of care for opioid use disorder for a tribal nation in the United States. Addiction, 10.1111/add.16184. Advance online publication.

Congratulations to Dr. Jana Zwilling and her colleagues on their recent publication! Early implementation of full-practice authority: A survey of Massachusetts nurse practitioners. O’Reilly-Jacob, Monica PhD, FNP-BC (Assistant Professor)1; Zwilling, Jana PhD, FNP-C (Clinical Assistant Professor)2; Perloff, Jennifer PhD (Senior Scientist)3; Freeman, Patricia BSN(c) (Undergraduate Nursing Student)1; Brown, Emily RN, MSN(c) (Graduate Nursing Student)1; Donelan, Karen ScD, EdM (Stuart H. Altman Professor and Chair in U.S. Health Policy)3. Early implementation of full-practice authority: A survey of Massachusetts nurse practitioners. Journal of the American Association of Nurse Practitioners. Read it at

Congratulations to Dr. Julie Hess and Madeline Comeau on their recent publication! Modeling lacto-vegetarian, pescatarian, and “pescavegan” USDA food patterns and assessing nutrient adequacy for healthy non-pregnant, non-lactating adults. Frontiers in Nutrition.

Congratulations to Dr. Rhoda Owens and Dr. Dawn Denny on being MNRS presenters! Owens, R.A., & Dawn, D.L. “Undergraduate Pre-licensure: Student Learning Experiences and Professional Identity in Nursing Formation”. Midwest Nursing research Society. March 29-April 1, 2023. Des Moines, Iowa.

Congratulations to Sydney Johnson on being a MNRS presenter! Johnson, S. R., Owens, R.A., & Denny D.L. “Simulation to Mitigate Moral Distress Among Nurses: Engaging the Affective Domain”. Midwest Nursing Research Society. March 29-April1, 2023. Des Moines, Iowa.

Congratulations to Rebecca Smith on being a MNRS presenter! Smith, R, & Denny, D.L. “Social Determinants of health and Prediction of Adverse Pregnancy Outcomes”.

Congratulations to Dr. Dawn Denny on being a MNRS presenter! Denny, D.L., Lindseth, G., Ferraro, R, & Petros, T. “Wellness and resilience of underrepresented, disadvantaged undergraduate students”.

Upcoming Events

CNPD Research and Scholarship Day is April 28, 2023
10 a.m. – 1p.m. | Memorial Union Ballroom

Undergraduate students, graduate students, and faculty from the College of Nursing & Professional Disciplines will present their research and other scholarly activities in the areas of Social Work, Nursing, and Nutrition & Dietetics. Student scholars are celebrated without the pressure of competition!

Funding Opportunities

-Sent on behalf of the VPR; please see attachments for the call for white papers.

-Sent on behalf of the UND VPR.

Please see the funding opportunity announcements.

Announcement of Combat Casualty Care Program

  • This RPP is focused on developing a multi-institutional, interdisciplinary network of universities, companies, military laboratories, and investigators designed to promote a seamless integration of development, from research through translational and clinical research, as the best means of bringing regenerative medicine therapies to practice.
  • The goal of this program is to accelerate the development of regenerative medicine prototypes to restore function to and heal injured Warfighters using this collaborative network, or consortium. The intent of the RPP is to make a single award to a Coordinating Site that can leverage the combined expertise of the DoD, industry, and academia to advance regenerative medicine prototypes to the clinic. For more details, please visit

Announcement of Spinal Cord Injury Research Program

  • Clinical Trial Award
  • Clinical Translation research Award
  • Translational Research Award
  • Investigator-Initiated Research Award

Announcement of Amyotrophic Lateral Sclerosis Research Program

  • Pilot Clinical Trial Award
  • Therapeutic Development Award
  • Clinical Biomarker Development Award
  • Therapeutic Idea Award

Announcement of Breast Cancer Research Program

  • Transformative Breast Cancer Consortium Award
  • Transformative Breast Cancer Consortium Development Award
  • Clinical Research Extension Award
  • Breakthrough Award Levels 1 and 2
  • Breakthrough Award Level 3
  • Breakthrough Award Level 4
  • The Era of Hope Scholar Award
  • Innovator Award

Announcement of Epilepsy Research Program

  • Leveraging Research Award
  • Virtual Post-Traumatic Epilepsy Research Center (P-TERC) – Faculty Award
  • Idea Development Award
  • Research Partnership Award

Announcement of Peer Reviewed Medical Research Program

  • Clinical Trail Award
  • Discovery Award
  • Focused Program Award
  • Investigator-Initiated Research Award
  • Lifestyle and Behavioral Health Interventions Research Award
  • Technology/Therapeutic Development Award

Announcement of Military Burn Research Program (MBRP)

Announcement of Tuberous Sclerosis Complex Research Program

Announcement of Combat Readiness-Medical Research Program (CRRP)

Announcement of Tick-Bourne Disease Research Program (TBDRP)

Announcement of Peer reviewed Alzheimer’s Research Program (PRARP)

  • Transforming Research Award ($1M/3 years)
  • Transforming Diagnosis Award ($2.5M/4 years)
  • Transforming Care Award ($1M/$1.2M CITPO/4 years)
  • All funding mechanisms include a Career Initiation and Transition Partnering Option (CITPO) where one project is jointly awarded with two Principal Investigators (PIs) working collaboratively, either at the same institution or separate ones. For more details, please review the funding opportunity announcement.
  • Pre-application Letter of Intent are due 31 May 2023.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at prior to the pre-application deadline. All applications must conform to the final Funding Opportunities/Program Announcements and General Application Instructions which can be found on the website ( A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420.

Announcement of Registration and Call for Abstracts for May 16-17,2023, NIDA Genetics and Epigenetics Meeting, Natcher Conference Center, NIH, Bethesda MD

The goals of the meeting are to:

  • Showcase the exciting research on the genetics and epigenetics of substance use disorders.
  • Encourage collaboration among investigators with different expertise in genetics and epigenetics.
  • Foster collaboration between investigators working on the genetics and epigenetics of substance abuse disorders and HIV/AIDS investigators.
  • Identify new research opportunities in the genetics and epigenetics of substance use disorders.
  • Provide attendees with an opportunity to meet with NIDA program directors to discuss their ideas for grant applications and funding opportunities.

Announcement of Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain (NOT-DA-20-039)

  • The purpose of the Notice is to encourage investigators to submit grant applications to the National Institute on Drug Abuse (NIDA) to study the effects of cannabis and cannabinoid exposure on the developing brain, from pre-, peri-, and post-natal development through young adulthood in humans and using animal models.
  • Application due dates: Standard dates apply by 5:00 PM local time of applicant organization.

Announcement of Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) (RFA-DA-23-056)

  • This Funding Opportunity Announcement (FOA) will support transformative research to identify and validate mechanisms, signaling pathways, and therapeutic targets, for understanding and reversing the effects of an overdose and the observed toxicities caused by acute Ultra-Potent Synthetic (UPS) opioid exposure. This FOA will also support mechanistic studies of persistent or delayed pathophysiological effects be acute exposure to UPS opioids.
  • Application Due Date (New and Renewal/Resubmission/Revision): November 17,2023, and November 19, 2024
  • Link to the RFA:

Announcement of Notice of Intent to Publish a Funding Opportunity Announcement for NIH Brain Development Cohorts Biospecimen Access (X01 Clinical Trial Not Allowed) (NOT-DA-22-064)

  • The National Institute on Drug Abuse intends to promote a new resource access program by publishing a Funding Opportunity Announcement (FOA) to seek applications for the following: NIH Brain Development Cohorts (NBDC) Biospecimen Access Program (X01- Clinical Trial Not Allowed). This FOA will allow investigators to apply for access to biological samples from the Adolescent Brain Cognitive Development (ABCD) Study. By making these specimens available to the greater scientific community, this resource award seeks to maximize the scientific potential of the biospecimens collected in the ABCD Study and expand the scope of ABCD’s open science model, allowing scientists from around the world to utilize these specimens and enrich the child and adolescent health data being obtained from the ABCD Study.
  • No funds will be provided through this opportunity. Applicants will be responsible for costs associated with conducting the research and sample shipment. Applicants will need to submit proof of funding for costs of analyses and sample shipment at the time of application.
  • This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
  • The FOA is expected to be published in Spring 2023, with an expected application due date in Summer 2023.
  • This FOA will utilize the X01 activity code. See the notice for more details of planned FOA.

Announcement of Education Activities for Responsible of Complex, Large-Scale Data (R25-Clinical Trial Not Allowed) (RFA-DA-24-027)

  • This FOA will support creative educational activities with a primary focus on methodological rigor in the analysis of large complex datasets involving brain, behavior, genomic, and socioenvironmental data. This could involve:
    • Courses for skills Development: For example. Advanced statistics and research design courses in a specific discipline or research area, rigor and robustness in research practice, or ethical conduct of biomedical research.
    • Curriculum or Methods Development: For example, to improve biomedical, behavioral or clinical science education, or develop novel instructional approaches or computer-based educational tools that support methodological rigor in analysis of large complex datasets.


  • This Funding Opportunity Announcement (FOA) encourages applications that seek to advance methodological rigor in biomedical and behavioral research by supporting training on the responsible analyses of complex, large-scale datasets involving brain, behavioral, genomic, and socioenvironmental data.

Topics of interest include, but are not limited to:

  • Analytical approaches for large-scale, longitudinal data
    • Enhanced rigor and robustness in research practice (e.g., pre-registration of experimental protocols, plans, and analyses)
    • Estimation of meaningful associations, including population inferences, effect sizes, control of covariates, and interpretation of associations
    • Ethical conduct of biomedical and behavioral research, including consideration of social constructs such as race/ethnicity and gender and the potential for stigmatization
    • Community-partnered research to inform data analyses and interpretation
    • Consideration of socioenvironmental contexts known to introduce inequities, such as family income and education, employment, housing, neighborhood-level characteristics, and exposure to violence
    • Factors to consider when examining the influence of socioenvironmental factors (e.g., non-random data missingness, sampling methodologies)
  • In addition, NIDA emphasizes responsible analyses of data related to neurodevelopment and neurocognition as it relates to the substance use trajectory.
  • Research education programs may complement ongoing research training and education occurring at the applicant institution, but the proposed educational experiences must be distinct from those training and education programs currently receiving Federal support. R25 programs may augment institutional research training programs (e.g.., T32, T90) but cannot be used to replace or circumvent Ruth L. Kirschstein National Research Service Award (NRSA) programs.
  • Application Deadline: February 8,2024, 5:00 PM local time of applicant organization.

Announcement of Job Opening for Data Science (Neuroinformatics) Program Officer

To apply:

The National Institute on Drug Abuse (NIDA), Division of Neuroscience and Behavior (DNB), Office of the Director is currently recruiting for a data science Program Officer. The mission of the Division of Neuroscience and Behavior is to discover, facilitate and promote outstanding basic animal and human research supporting the mission of NIDA, to identify the causes and consequences of drug addiction and misuse across the lifespan, and to guide treatment strategies. DNB develops and supports an extramural research program that will advance the understanding of the genetic, chemical, neurobiological and behavioral mechanisms of addictive drugs and their long-term consequences. Research related to the neurological bases of reward and the behaviors that characterize the cycle of addiction is a primary focus of DNB. Additionally, an integral component of DNB’s scientific mission is to grow and maintain a diverse workforce that is dedicated to these research goals and is supported through training initiatives that span from predoctoral level to mid-stage investigator. The Office of the Director directs, coordinates, and supports the Division’s missions and activities through maintaining and evaluating strategic directions and goals, supporting goals through the branch structure, and developing and leveraging collaborations and activities across NIDA and NIH. The data science Program Officer would be responsible for assisting in the management of a research portfolio of grants using data science approaches to advance science on the causes of consequences of drug use and addiction. Additionally, the grant portfolio would include data curation, sharing, access, reproducibility, security, analysis, harmonization, quality metrics and standards, and visualization. The data science program officer would also serve as a representative for NIDA on NIH-wide and multi-agency committees.

For additional information about this position, please contact Dr. Roger Little,



Leave a Comment

Your email address will not be published. All comments will be reviewed prior to posting.